BPC-157
BPC-157 is a synthetic peptide of 15 amino acids, based on a fragment of a protein in gastric juice.
Also listed as PL 14736, PL-10, Bepecin
What it is studied for
The strongest rated effects first. Bars show the size of the effect, the letter grades the evidence, and each rating lists the studies behind it.
Why is this peptide being studied?
BPC-157 is an experimental peptide investigated for tissue repair. A 2025 review found encouraging results in animal muscle, tendon, ligament and bone-injury models. Proposed pathways include new blood-vessel formation and signals involved in cell growth; these mechanisms are hypotheses for human benefit. 1
Why people take it
SuppCo community snapshot, 2026-09-28. Reasons for use are not evidence that it works.
Questions people ask
Do animal healing results prove it works in people?
No. They identify a reason for clinical research, but do not demonstrate human tendon or fracture healing. 1
Is there an established recovery dose?
The human review does not establish an effective, safe regimen. Its small studies used different routes and lacked control groups. 2
Is compounded BPC-157 FDA-approved?
No. Conditional enforcement discretion for compounding does not constitute FDA approval. 3
Is BPC-157 allowed outside competition?
Under the 2026 WADA list it is prohibited at all times, including outside competition. 4
Sources
- HHS Enforcement Discretion Policy Regarding 503A Compounding Using Certain Peptide Bulk Drug Substances US Department of Health and Human Services, 2026
- The 2026 Prohibited List World Anti-Doping Agency; hosted by NADA Austria, 2026
